Similar companies
Income Statement ()
| Q3 '24 | QoQ |
|---|
Balance Sheet ()
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 397B | 7.6% |
| Total Liabilities | 277B | 7.8% |
| Total Equity | 121B | 7.1% |
Cash Flow ()
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | 43.9B | 13.2% |
| Cash from financing | -18.4B | 210.3% |
Financial Highlights for Novo Nordisk in Q3 '24
Novo Nordisk faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. A decline in EBITDA signals potential operational challenges or increased costs.
